CION Ameerpet
Before You Start Immunotherapy
Getting a second opinion before immunotherapy — what it checks, and whether it slows you down
A second opinion before immunotherapy re-checks your biopsy, biomarker report and cancer stage before you commit real time and money to it. It rarely delays treatment by more than a few days, and for a meaningful share of patients it confirms they are not actually eligible for immunotherapy at all — useful information either way.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Checks eligibility first — confirms whether you're actually a candidate for immunotherapy before any money is spent; most people who ask aren't
- Re-reads the biomarker report — a second, independent look at PD-L1, MSI or NGS results, since interpretation can genuinely vary between labs
- Works for families abroad — reports and scans can be reviewed remotely by video, so relatives funding treatment from overseas don't need the patient to travel for this step
- Usually a matter of days — a document-based review rarely holds up a genuinely time-sensitive treatment decision
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Start Here
What should a second opinion review actually check?
A proper second opinion re-examines your original histopathology slides or report, checks whether biomarker testing — PD-L1, MSI/MMR, or a broader NGS panel — was done correctly and interpreted accurately, confirms the cancer stage, and asks whether immunotherapy is genuinely indicated for your specific case. It is a structured audit of the plan, not a polite second look that rubber-stamps what you were already told.
Most patients who ask about immunotherapy are not eligible for it. It is approved for specific cancers, often only at certain stages, and usually requires a positive biomarker result before it is used at all. A good second opinion will say this plainly if it applies to you, rather than implying immunotherapy is worth trying regardless — confirming ineligibility early is exactly the kind of finding a second opinion exists to catch, before you spend on it.
The rest of this page sets out which reports to bring, how long a review genuinely takes, and why a second opinion at this stage is closer to financial due diligence than a loss of confidence in your first oncologist.
Did you know?
PD-L1 testing uses several different antibody assays across laboratories, and results near the eligibility cut-off aren't always read the same way by every lab. Pathology and oncology bodies (CAP/ASCO) recommend that borderline biomarker results be confirmed by specialist review before a treatment decision is finalised — exactly what a second opinion is built to do.
Before You Book
Which reports are needed for a second opinion?
Bringing the right documents — not just a summary of what you were told — is what makes a review genuinely useful.
Biopsy report
Original histopathology report
The full pathology report, and where possible the physical slides or blocks, so they can be re-read if needed — not just the one-line summary.
Biomarker report
PD-L1, MSI/MMR, or NGS panel
Any molecular or immunohistochemistry testing already done. This is the single most important document for an immunotherapy-specific second opinion.
Imaging
Scan images, not just the report
CT or PET-CT images on a disc or a shareable digital link. A typed radiology report alone leaves the reviewing oncologist working blind on the actual scans.
Treatment history
Summary of care so far
Dates and details of any surgery, chemotherapy, or radiation already given, plus discharge summaries from prior admissions.
General health
Current medications and conditions
Existing autoimmune disease, organ function, and current medications all affect fitness for immunotherapy specifically.
Missing one of these doesn't stop a second opinion from starting — it just means the reviewing oncologist may ask for it before giving a final view.
Timing
Will getting a second opinion delay starting immunotherapy?
Usually not in any way that matters clinically. A document-based second opinion on existing reports and scans can typically be completed within a few days, since it doesn't require repeating major tests unless something looks inconsistent or incomplete. Immunotherapy decisions are rarely so time-critical that a short, well-organised review meaningfully changes the outcome.
For families coordinating care from outside India, the whole process can run remotely: reports and scans are shared digitally or couriered, and the consultation itself happens over video. The patient doesn't need to travel just for this step, and a relative funding treatment from abroad can be part of the conversation directly rather than relying on a second-hand summary.
If a review does raise a genuine question — a borderline biomarker result, or a staging discrepancy — that extra day or two of clarity is time well spent before committing to a multi-cycle treatment course.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get clarity before you commit
A free, doctor-led review of your existing reports — no pressure to switch care, no commitment to start treatment.
Not Doubt — Due Diligence
Isn't a second opinion only for patients who doubt their oncologist?
No — most oncologists expect and welcome one, especially before a treatment at this level of cost and commitment. At this price point, a second opinion is financial due diligence, not a vote of no confidence. It matters most in these situations:
High cost, one shot
The cost of immunotherapy itself
Immunotherapy is typically a multi-cycle course, not a single procedure. Verifying eligibility and plan accuracy first protects a financial commitment of this size — costs are always indicative and confirmed directly with your oncology team, not quoted against any specific drug here.
Borderline biomarker result
When the result is right on the line
Borderline PD-L1 or MSI results are exactly where lab-to-lab interpretation can genuinely differ — this is where a second, expert read matters most.
Complex or rare diagnosis
Uncommon or advanced-stage cancers
Rarer tumour types, or disease that has already spread, benefit most from an additional, independent set of eyes on the same reports.
Family funding decisions
When family is arranging care from abroad
Relatives funding or coordinating treatment from overseas often want independent verification before committing funds and travel plans — a second opinion gives them that, directly.
If The Answer Is No
What happens if the second opinion doesn't recommend immunotherapy?
This is a common, legitimate outcome — not a failed review. As stated plainly above, most patients who ask about immunotherapy are not actually candidates for it, usually because of biomarker status, cancer type, or stage. A second opinion that says so clearly has done exactly what it was meant to do: given you an honest answer before, not after, you commit.
If immunotherapy genuinely isn't the right fit, the realistic paths your oncology team should discuss with you honestly include a different systemic treatment approach, a relevant clinical trial where one exists, or best supportive care focused on comfort and quality of life. Choosing not to pursue immunotherapy — or not to pursue further active treatment at all — is a real, respected option in this conversation, decided with your team, not imposed by a report.
A disagreement between two second opinions is also useful information, not a crisis — it usually points to a specific question (often a biomarker result) worth clarifying, and the final decision always stays with you and your family.
Related Reading
Understanding the decision more fully
- Immunotherapy for Stage 4 Cancer: What It Can and Cannot Achieve — useful context if your second opinion is being sought for advanced-stage disease.
- Will I Lose My Hair on Immunotherapy? — a common side-effect question worth raising in the same review as eligibility.
- Immunotherapy as a First Treatment vs After Chemotherapy — treatment sequencing is one of the things a thorough second opinion checks.
- Immunotherapy at CION Cancer Clinics — the full picture of how CION supports patients through this decision.
This page is for general information and does not replace a consultation. It does not name or recommend any specific medicine, and any cost figures referenced are indicative only, as of August 2026, and confirmed directly with your oncology team.
You're not alone
Most families ask for a second opinion before immunotherapy
Wanting an independent check before a major treatment decision is common sense, not distrust. Our team reviews your reports honestly, either way.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Second opinions before immunotherapy: your questions answered
What should a second opinion review actually check?
A proper second opinion re-examines your original histopathology slides or report, checks whether the biomarker testing (such as PD-L1, MSI, or TMB) was done correctly and interpreted accurately, confirms the cancer stage, and asks whether immunotherapy is genuinely indicated for your specific case — or whether another approach fits better. It is a structured audit of the plan, not just a friendly nod to what you were already told.
Which reports do I need to bring for a second opinion?
Bring the original biopsy or histopathology report, any biomarker or molecular testing report (PD-L1, MSI/MMR, or an NGS panel if one was done), imaging with the actual scan images on disc or a shareable link — not just the typed report — and a summary of any treatment already given. A reviewing oncologist working from typed summaries alone can miss details that change the recommendation, so the original films matter as much as the reports.
Will getting a second opinion delay starting immunotherapy?
Usually not in any way that matters clinically. A document-based second opinion on existing reports and scans can typically be completed within a few days, since it doesn't require repeating major tests unless something looks inconsistent or incomplete. Immunotherapy decisions are rarely so time-critical that a short, well-organised review meaningfully changes the outcome — and confirming the right plan first can save far more time than it costs.
Isn't asking for a second opinion an insult to my first oncologist?
No — most oncologists expect and welcome it, especially before a treatment with this level of cost and commitment. At this price point, a second opinion is financial due diligence, not a vote of no confidence. A second, independent read of the same reports either confirms the plan — which is reassuring — or catches something worth discussing before you commit, which protects you either way.
Can a second opinion be arranged remotely for family based outside India?
Yes. Reports, scans, and biomarker results can be shared digitally or couriered, and the consultation itself can be done over video, so a relative funding or coordinating care from abroad does not need the patient to travel for this step. Many second-opinion requests for immunotherapy decisions specifically come from family members organising care remotely.
What if the second opinion disagrees with the first?
A disagreement is useful information, not a crisis. It might mean the two oncologists are weighing the same facts differently, that additional testing (often biomarker retesting) would clarify things, or that one plan fits your specific goals and fitness better than the other. Either way, you and your family — not either oncologist alone — make the final decision, ideally after asking both teams to explain their reasoning directly.